First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
32.09
+0.65 (2.05%)
At close: Nov 21, 2025, 4:00 PM EST
32.72
+0.63 (1.98%)
After-hours: Nov 21, 2025, 4:38 PM EST

FTXH Holdings Information

FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Johnson & Johnson stock at 7.41%, Merck & Co. at 7.29%, AbbVie at 7.05%, Pfizer at 6.37%, and Bristol-Myers Squibb Company at 6.29%.

Total Holdings
25
Top 10 Percentage
55.43%
Asset Class
Equity
ETF Category
Health
Assets
18.96M
PE Ratio
17.21

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1JNJJohnson & Johnson7.41%6,874
2MRKMerck & Co., Inc.7.29%14,477
3ABBVAbbVie Inc.7.05%5,788
4PFEPfizer Inc.6.37%49,185
5BMYBristol-Myers Squibb Company6.29%25,812
6LLYEli Lilly and Company4.60%831
7CAHCardinal Health, Inc.4.51%4,093
8REGNRegeneron Pharmaceuticals, Inc.4.10%1,048
9BIIBBiogen Inc.4.04%4,522
10AMGNAmgen Inc.3.77%2,116
11GILDGilead Sciences, Inc.3.57%5,390
12VRTXVertex Pharmaceuticals Incorporated3.49%1,557
13UTHRUnited Therapeutics Corporation3.43%1,363
14VTRSViatris Inc.3.12%57,716
15JAZZJazz Pharmaceuticals plc2.67%2,864
16ZTSZoetis Inc.2.39%3,893
17ILMNIllumina, Inc.1.92%3,034
18PTCTPTC Therapeutics, Inc.1.76%4,349
19INCYIncyte Corporation1.66%3,081
20EXELExelixis, Inc.1.34%6,067
21CRLCharles River Laboratories International, Inc.1.28%1,493
22MEDPMedpace Holdings, Inc.1.26%406
23ELANElanco Animal Health Incorporated1.06%9,430
24BMRNBioMarin Pharmaceutical Inc.0.99%3,559
25HALOHalozyme Therapeutics, Inc.0.85%2,317
Showing 25 of 51 holdings
Subscribe to see the full list
As of Nov 19, 2025